Диссертация (1140247), страница 18
Текст из файла (страница 18)
Patel A, Wang D, Sainani N, Sayuk GS, Gyawali CP. Distal mean nocturnalbaseline impedance on pH-impedance monitoring predicts reflux burden andsymptomatic outcome in gastro-oesophageal reflux disease. Aliment PharmacolTher. 2016; 44:890–898.160. Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motorcorrelate of heartburn symptom.
Am J Physiol Gastrointest Liver Physiol 2001;281:G743-G751.161. Perretta S, Fisichella PM, Galvani C, et al. Achalasia and chest pain: effect oflaparoscopic Heller myotomy. J Gastrointest Surg 2003; 7:595-598.162. Pimentel M, Rossi F, Chow EJ, Ofman J, Fullerton S, Hassard P, et al. Increasedprevalence of irritable bowel syndrome in patients with gastroesophageal reflux.J Clin Gastroenterol 2002; 34:221-4.163.
Poh CH, Gasiorowska A, Navarro-Rodriguez T, et al. Upper GI tract findings inpatients with heartburn in whom proton pump inhibitor treatment failed versusthose not receiving antireflux treatment. Gastrointest Endosc 2010; 71:28-34.164. Ponce J, Ortiz V, Maroto N, et al. High prevalence of heartburn and low acidsensitivity in patients with idiopathic achalasia.
Dig Dis Sci 2011; 56:773-776.165. Porter RF, Kumar N, Drapekin JE, et al. Fragmented esophageal smooth musclecontraction segments on high resolution manometry: a marker of esophagealhypomotility. Neurogastroenterol Motil 2012; 24:763-768, e353.166. Prakash C, Clouse RE.
Wireless pH monitoring in patients with non-cardiacchest pain. Am J Gastroenterol 2006; 101:446-452.167. Rao SS, Gregersen H, Hayek B, et al. Unexplained chest pain: thehypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med1996; 124:950-958.168. Rasmussen S, Jensen TH, Henriksen SL, Haastrup PF, Larsen PV, SøndergaardJ, Jarbøl DE. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia107and irritable bowel syndrome in the general population. Scand J Gastroenterol.2015 Feb; 50(2):162-9.169. Richter J.
Provocative tests in esophageal diseases. Front Gastrointest Res 1994;22:188.170. Richter JE. Chest pain and gastroesophageal reflux disease. J Clin Gastroenterol2000; 30:S39-41.171. Rodrigo S, Abboud G, Oh D, et al. High intraepithelial eosinophil counts inesophageal squamous epithelium are not specific for eosinophilic esophagitis inadults. Am J Gastroenterol. 2008; 103:435–442.172. Roman S, Lin Z, Kwiatek MA, et al. Weak peristalsis in esophageal pressuretopography: classification and association with dysphagia. Am J Gastroenterol2011; 106: 349-356.173. Rome IV.
Functional Gastrointestinal Disorders: in 2 vol. / Drossman D.A. et al.– Rome Foundation, 2016.174. Rosenstock A, Kushnir V, Patel A. Diagnostic yield in the evaluation ofdysphagia. Gastrointest Endosc 2011; 73:AB 287.175. Rowley H, O’Dwyer TP, Jones AS, et al.
The natural history of globuspharyngeus. Laryngoscope 1995; 105:1118-1121.176. Russo MW, Gaynes BN, Drossman DA. A national survey of practice patterns ofgastroenterologists with comparison to the past two decades. J Clin Gastroenterol1999; 29:339-343.177. Sarkar S, Thompson DG, Woolf CJ, et al. Patients with chest pain and occultgastro-esophageal reflux demonstrate visceral pain hypersensitivity which maybe partially responsive to acid suppression. Am J Gastroenterol 2004; 99:19982006.178. Savarino E, de Bortoli N, Bellini M, et al.
Practice guidelines on the use ofesophageal manometry - A GISMAD-SIGE-AIGO medical position statement.Dig Liver Dis. 2016; 48:1124–1135.108179. Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pHmonitoring to Rome III criteria in distinguishing functional heartburn from nonerosive reflux disease. Dig Liver Dis 2011; 43542-547.180. Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes andsymptom association in patients with erosive esophagitis and nonerosive refluxdisease: study using combined impedance-pH off therapy.
Am J Gastroenterol2010; 105: 1053-1061.181. Savarino E, Zentilin P, Lo Cuoco D, Frazzoni M, De Bortoli N, Casini V, et al.Symptoms associated to weakly acidic reflux and esophageal motilityabnormalities are more common than functional chest-pain in patients with noncardiac chest pain refractory to ppi therapy. Gut 2012; 61(Suppl 3):A431.182. Savarino E, Zentilin P, Marabotto E, et al. Drugs for improving esophagealmucosa defense: where are we now and where are we going? Annals ofGastroenterology. 2017; 30(6):585-591.183.
Savarino E, Zentilin P, Mastracci L, et al. Microscopic esophagitis distinguishespatients with non-erosive reflux disease from those with functional heartburn. JGastroenterol 2013; 48:473-482.184. Savarino E, Zentilin P, Savarino V. The reason for failure of on-demand PPItherapy in NERD patients. Neurogastroenterol Motil. 2011 Aug; 23(8):811.185. Savarino E, Zentilin P, Tutuian R, et al. Impedance-pH reflux patterns candifferentiate non-erosive reflux disease from functional heartburn patients. JGastroenterol 2012; 47:159-168.186.
Savarino E, Zentilin P, Tutuian R, Pohl D, Casa DD, Frazzoni M, Cestari R,Savarino V. The role of nonacid reflux in NERD: lessons learned fromimpedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008;103:2685–2693.187. Schey R, Dickman R, Parthasarathy S, et al. Sleep deprivation is hyperalgesic inpatients with gastroesophageal reflux disease. Gastroenterology 2007; 133:17871795.109188. Shapiro M, Green C, Bautista JM, et al. Functional heartburn patientsdemonstrate traits of functional bowel disorder but lack a uniform increase ofchemoreceptor sensitivity to acid.
Am J Gastroenterol 2006; 101:1084-1091.189. Sichuan Da Xue Xue Bao Yi Xue Ban. Symptom overlaps between functionalheartburn, functional dyspepsia, and irritable bowel syndrome. 2014 May;45(3):489-92.190. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring:review and consensus report on detection and definitions of acid, non-acid, andgas reflux.
Gut. 2004 Jul; 53(7):1024-31.191. Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J. Weakly acidicreflux in patients with chronic unexplained cough during 24 hour pressure, pH,and impedance monitoring. Gut. 2005 Apr; 54(4):449-54.192. Sifrim D, Holloway RH, Silny J. et al. Non-acid gastroesophageal reflux //Gastroenterology. – 2001. – Vol. 120 – P. 436 [Abstract].193.
Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptomsrefractory to proton pump inhibitors. Gut 2012; 61:1340-1354.194. Slaughter JC, Goutte M, Rymer JA, et al. Caution about overinterpretation ofsymptom indexes in reflux monitoring for refractory gastroesophageal refluxdisease. Clin Gastroenterol Hepatol 2011; 9:868-874.195. Sperber AD, Dekel R.
Irritable bowel syndrome and co-morbid gastrointestinaland extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil.2010 Apr; 16(2):113–119.196. Szczesniak MM, Fuentealba SE, Cook IJ. Acid sensitization of esophagealmucosal afferents: implication for symptom perception in patients across thegastroesophageal reflux disease spectrum. Clin J Pain 2013; 29:70-77.197.
Tack J. Is there a unifying role for visceral hypersensitivity and irritable bowelsyndrome in non-erosive reflux disease? Digestion. 2008; 78 Suppl 1:42-5.198. Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, CrowellMD. Overlapping upper and lower gastrointestinal symptoms in irritable bowel110syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454-9.199. Tang Y, Huang J, Zhu Y, Qian A, Xu B, Yao W.
Comparison of esophagealmotility in gastroesophageal reflux disease with and without globus sensation.Rev Esp Enferm Dig. 2017 Dec; 109(12):850-855.200. Tobey NA, Hosseini SS, Argote CM, et al. Dilated intercellular spaces and shuntpermeability in nonerosive acid-damaged esophageal epithelium. Am JGastroenterol 2004; 99:13-22.201. Tougas G, Spaziani R, Hollerbach S, et al. Cardiac autonomic function andoesophageal acid sensitivity in patients with non-cardiac chest pain.
Gut 2001;49:706-712.202. Trimble KC, Farouk R, Pryde A, Douglas S, Heading RC. Heightened visceralsensation in functional gastrointestinal disease is not site-specific. Evidence for ageneralized disorder of gut sensitivity. Dig Dis Sci 1995; 40:1607-13.203. Tsoukali E, Sifrim D. The role of weakly acidic reflux in proton pump inhibitorfailure, has dust settled? J Neurogastroenterol Motil. 2010 Jul; 16(3):258-64.204. Tutuian R, Castell DO. Clarification of the esophageal function defect in patientswith manometric ineffective esophageal motility: studies using combinedimpedance-manometry.
Clin Gastroenterol Hepatol 2004; 2:230-236.205. Vela MF, Craft BM, Sharma N, et al. Refractory heartburn: comparison ofintercellular space diameter in documented GERD vs. functional heartburn. AmJ Gastroenterol 2011; 106:844-850.206. von Rahden BH, Stein HJ, Becker K, et al. Heterotopic gastric mucosa of theesophagus: literature-review and proposal of a clinicopathologic classification.Am J Gastroenterol 2004; 99:543-551.207. Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing aneffective approach to diagnose gastroesophageal reflux disease in patients withnoncardiac chest pain? A meta-analysis.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
